SQUAWK/NEWS
Menu
Live News EQUITY L impact

CRIS Curis announces positive emavusertib update Curis - to dose initial 5 takeaim cll patients by end of July; data expected December 2026

CRIS Curis announces positive emavusertib update Curis - to dose initial 5 takeaim cll patients by end of July; data expected December 2026

CRIS Curis announces positive emavusertib update Curis - to dose initial 5 takeaim cll patients by end of July; data expected December 2026